Valerian for Anxiety

Verdict: Weak, inconsistent evidence for anxiety

Valerian is not a proven treatment for anxiety. The only randomized trial done specifically for an anxiety disorder found no benefit over placebo, and the somewhat more encouraging data really describe sleep and sedation rather than anxiety itself.

C 🟠 C Weak Evidence Taiwan Regulatory Restriction

🔬Why this grade7-layer evidence engine

The grade is held to weak (Tier C) because human evidence aimed directly at anxiety is both scarce and unconvincing. A Cochrane systematic review (PMID 17054208) could locate just one small randomized trial (n=36), in which valerian was no better than placebo on HAM-A anxiety scores and was outperformed by diazepam on the STAI trait scale.

Later work is suggestive but does not lift the verdict. A 2020 meta-analysis (PMID 33086877, n=535) reported a pooled reduction in anxiety, yet the effect was inconsistent across studies and the analysis was anchored in sleep research, where valerian's signal is stronger. A 2021 crossover trial in dialysis patients (PMID 33936782, n=39) showed a Phase 1 drop in state anxiety, but the result did not hold up consistently in the second phase.

Authorities reinforce the cautious read. The WHO monograph backs valerian only as a mild sedative for anxiety-related sleep disturbance, not as a treatment for anxiety disorders, and the US FDA recognizes it merely as a flavoring agent, not for any health claim. A drug-interaction flag also applies: valerian can add to the sedation of benzodiazepines, alcohol, and other CNS depressants. The plausible calming mechanism keeps this above outright 'no effect,' but the data fall well short of establishing real benefit.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.46
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Taiwan Regulatory Restriction
Confidence
75%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.40
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.53
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.464
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高階證據未達主導 (0 positive vs 1 negative),由 raw_score 決定
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Valerian for anxiety disorders
PMID: 17054208 2006 系統性回顧 n = 36
Finding: Only 1 small RCT identified; no significant difference between valerian and placebo on HAM-A total scores; diazepam outperformed valerian on STAI-Trait.
🟠 Limited quality
View on PubMed
Valerian Root in Treating Sleep Problems and Associated Disorders - A Systematic Review and Meta-Analysis
PMID: 33086877 2020 統合分析 n = 535
Finding: Pooled analysis found valerian effective for reducing anxiety, with benefits noted as optimized when combined with herbal partners; effect inconsistent across studies.
View on PubMed
The Effects of Valerian on Sleep Quality, Depression, and State Anxiety in Hemodialysis Patients: A Randomized, Double-blind, Crossover Clinical Trial
PMID: 33936782 2021 RCT (double-blind) n = 39
Finding: Phase 1 showed greater state anxiety reduction with valerian vs placebo (14.6 vs 7.3, p=0.003), though crossover Phase 2 results were inconsistent.
🟠 Limited quality Effect size: MD ~7.3 points STAI state anxiety (Phase 1)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Neutral
Valerian Root Oil (Valeriana officinalis L.): 21 CFR 172.510; Used for: FLAVORING AGENT OR ADJUVANT; FEMA GRAS Publication No(s).: 3; FEMA No. 3100; CAS Reg. No. 8008-88-6. source↗
L4e WHO
Supportive
Medicinal uses. Uses supported by clinical data: As a mild sedative and sleep-promoting agent. The drug is often used as a milder alternative or a possible substitute for stronger synthetic sedatives, such as the benzodiazepines, in the treatment of states of nervous excitation and anxiety-induced sleep disturbances. Contraindications: Radix Valerianae should not be used during pregnancy or lac… source↗
L5d Harvard Health
Cautious
Valerian, derived from the root of a pink flower, can alleviate anxiety and help improve sleep just as well as some sedatives. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-anxiety-INT-valerian-001 繁體中文版 →